Professional Services
Biologics & Biosimilars
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process
Optimized Process Demonstrated Effective Removal of Procoagulant Impurities While Maintaining Immunoglobulin Quality and Increasing IgG Yield No...
Read more
Report
Children as young as 2 gain access to ADMA's ASCENIV after FDA approval
The label now covers primary humoral immunodeficiency patients ages 2 and up, down from 12+, widening ASCENIV's FDA-approved pediatric use.
Read more
Report
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV to Include Pediatric Immune Compromised Patients Two Years of Age and Older
RAMSEY, N.J. and BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (
Read more
Report
ADMA Biologics sets May 6 earnings webcast for 4:30 p.m. ET
Management hosts a live call at 4:30 p.m. ET to discuss quarterly results and company updates; a webcast replay will post in ADMA's investor hub.
Read more
Report
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research
Read more
Report
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
ADMAlytics Combines Generative AI and Machine Learning to Optimize Production Processes ADMA Successfully Utilized ADMAlytics' New Capabilities for the...
Read more
Report
ADMA Biologics, Inc. (ADMA) stock price, news, quote and history - Yahoo Finance
Find the latest ADMA Biologics, Inc. (ADMA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Read more
Report
